Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christopher, Rudge"'
Publikováno v:
Cambridge Prisms: Precision Medicine, Vol 1 (2023)
Clustered regularly interspaced short palindromic repeats and other genome editing technologies have the potential to transform the lives of people affected by genetic disorders for the better. However, it is widely recognised that they also raise la
Externí odkaz:
https://doaj.org/article/95171af0e39d458d9bad565991ff9752
Autor:
Christopher Rudge, Narcyz Ghinea
Publikováno v:
Australian Health Review. 47:182-191
Objective The personal importation scheme is a legislative mechanism that allows health consumers to import unapproved medicines under certain conditions. This article analyses the legal and policy basis for the scheme and considers how reforms to ad
Autor:
Christopher Rudge
Publikováno v:
Current Issues in Criminal Justice. 34:334-338
Publikováno v:
Journal of law and medicine. 29(3)
This section examines recent reforms to the regulatory framework for biologicals contained in the Therapeutic Goods Act 1989 (Cth) in the context of the "New Frontier" of reform envisioned in a report completed by the Commonwealth Government in 2021.
Publikováno v:
Journal of cell science. 135(1)
Current medicine has only taken us so far in reducing disease and tissue damage. Extracellular vesicles (EVs), which are membranous nanostructures produced naturally by cells, have been hailed as a next-generation medicine. EVs deliver various biomol
Autor:
Cameron, Stewart, Christopher, Rudge
Publikováno v:
Journal of law and medicine. 28(4)
This paper examines the public interest test and how it is employed in immediate action hearings under the Health Practitioner Regulation National Law. It examines the history of the test in New South Wales and its eventual adoption by other States a
Publikováno v:
Australian health review : a publication of the Australian Hospital Association. 45(4)
Objective This paper provides an update and overview of the law governing direct-to-consumer (DTC) advertising of autologous stem cell interventions (ASCIs) in Australia. It follows significant changes to the advertising regulations made in 2018. Met
Publikováno v:
Regenerative medicine. 15(2)
In 2018, Australia’s Therapeutic Goods Administration introduced regulatory reforms that set stricter criteria around the regulation of products derived from a patient’s own cells and tissues, posing significant implications for clinics offering
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation. 18(12)
Autor:
Christopher Rudge
Publikováno v:
Transplantation. 80(5)